FASEB J. Integrated DNA Technologies
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.08-119040.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Buy
Right arrow All Versions of this Article:
fj.08-119040v1
23/4/985    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huggins, A.
Right arrow Articles by D'Acquisto, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huggins, A.
Right arrow Articles by D'Acquisto, F.
(The FASEB Journal. 2009;23:985-996.)
© 2009 FASEB

Annexin-1-deficient dendritic cells acquire a mature phenotype during differentiation

Anthony Huggins, Nikolaos Paschalidis, Roderick J. Flower, Mauro Perretti and Fulvio D'Acquisto1

William Harvey Research Institute, Barts and The London Medical School, London, UK

1Correspondence: The William Harvey Research Institute, Barts and The London School of Medicine, Charterhouse Sq., London EC1M 6BQ, UK. E-mail: f.dacquisto{at}qmul.ac.uk

Dendritic cells play a key role in the adaptive immune system by influencing T-cell differentiation. Annexin-1 (Anx-A1) has recently been shown to modulate the adaptive immune response by regulating T-cell activation and differentiation. Here we investigated the role of endogenous Anx-A1 in dendritic cells as major cellular counterpart of T-cell-driven immune response. We found that Anx-A1–/– bone marrow-derived dendritic cells show an increased number of CD11c+ cells expressing high levels of some maturation markers, such as CD40, CD54, and CD80, coupled to a decreased capacity to take up antigen compared to control Anx-A1+/+ cells. However, analysis of LPS-treated dendritic cells from Anx-A1–/– mice demonstrated a diminished up-regulation of maturation markers, a decreased migratory activity in vivo, and an attenuated production of the inflammatory cytokines interleukin (IL)-1β, tumor necrosis factor (TNF)-{alpha}, and IL-12. This defect was also accompanied by impaired nuclear factor (NF)-{kappa}B/DNA-binding activity and lack of Anx-A1 signaling, as demonstrated by the reduced activation of extracellular-signal regulated kinase (ERK)1/2 and Akt compared to cells from control littermates. As a consequence of this phenotype, Anx-A1–/– dendritic cells showed an impaired capacity to stimulate T-cell proliferation and differentiation in mixed leukocyte reaction. Together, these findings suggest that inhibition of Anx-A1 expression or function in dendritic cells might represent a useful way to modulate the adaptive immune response and pathogen-induced T-cell-driven immune diseases.—Huggins, A., Paschalidis, N., Flower, R. J., Perretti, M., D'Acquisto, F. Annexin-1-deficient dendritic cells acquire a mature phenotype during differentiation.


Key Words: inflammation • antigen presenting cells • formyl peptide receptor ligand







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.